5325-89-3

Basic information

• Product Name: (2E)-1-(4-aminophenyl)-3-pyridin-2-ylprop-2-en-1-one
• Synonyms: (2E)-1-(4-Aminophenyl)-3-(pyridin-2-yl)prop-2-en-1-one; 2-propen-1-one, 1-(4-aminophenyl)-3-(2-pyridinyl)-, (2E)-
• CAS NO: 5325-89-3
• Molecular Formula: C₁₄H₁₂N₂O
• Molecular Weight: 224.2579
• Mol File: 5325-89-3.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 441°C at 760 mmHg
• Flash Point: 220.5°C
• Density: 1.21g/cm³
• Vapor Pressure: 5.62E-08mmHg at 25°C
• Refractive Index: 1.672
• CAS DataBase Reference: (2E)-1-(4-aminophenyl)-3-pyridin-2-ylprop-2-en-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2E)-1-(4-aminophenyl)-3-pyridin-2-ylprop-2-en-1-one(5325-89-3)
• EPA Substance Registry System: (2E)-1-(4-aminophenyl)-3-pyridin-2-ylprop-2-en-1-one(5325-89-3)

Safety Data

• Hazardous Substances Data: 5325-89-3(Hazardous Substances Data)

Usage

General Description

The chemical compound "(2E)-1-(4-aminophenyl)-3-pyridin-2-ylprop-2-en-1-one" is an organic compound with the molecular formula C14H12N2O. It is a yellow solid that is insoluble in water but soluble in organic solvents. (2E)-1-(4-aminophenyl)-3-pyridin-2-ylprop-2-en-1-one is a derivative of pyridine and contains a prop-2-en-1-one functional group. It has potential applications in medicinal chemistry and pharmaceutical research due to its structural features and potential biological activities. However, further research and testing are needed to fully understand its potential uses and properties.

Upstream product

• 1121-60-4 pyridine-2-carbaldehyde 
• 99-92-3 p-aminobenzophenone 
• 500-22-1 3-pyridinecarboxaldehyde 

Downstream Products

• 1266387-29-4 2-amino-4-(4-aminophenyl)-6-(2-pyridinyl)pyrimidine 
• 408365-26-4 N-{4-[(2E)-3-(2-pyridinyl)-2-propenoyl]phenyl}-4'-(trifluoromethyl)-1,1'-biphenyl-2-carboxamide 
• 408365-24-2 4'-amino-3-(pyridin-2''-yl)propiophenone 

Relevant articles and documents

Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents

Diabetes mellitus (DM) is a serious chronic metabolic disorder which occurs due to dysfunction of insulin and therapeutic approaches are poor. It is an under estimation that 387 million people currently suffering globally with diabetic and more than 592 m

Design, synthesis, molecular modeling, and ADMET studies of some pyrazoline derivatives as shikimate kinase inhibitors

A series of pyrazoline derivatives were synthesized and their structures have been characterized by IR, 1H NMR, 13C NMR, mass spectral and elemental analysis. The novel compounds were designed as Mycobacterium tuberculosis shikimate

In vitro antioxidant activity and scavenging effects of some synthesized 4-Aminochalcones

A new series of substituted 4'-aminochalcones were synthesized by Claisen-Schmidt condensation of 4-aminoacetophenone with various substituted aromatic/heteroaromatic aldehydes. The antioxidant activity for all these compounds were studied on various reac